MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis

Chemoresistance is one of the causes of poor prognosis in pancreatic cancer patients. However, the mechanisms of resistance remain unclear. Here we screened miRNAs associated with drug resistance in pancreatic cancer, and identified a panel of miRNAs dysregulated in gemcitabine-resistance pancreatic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Xu, Jianwei, Wang, Tianxiao, Cao, Zhe, Huang, Hua, Li, Jian, Liu, Wenjing, Liu, Shanglong, You, Lei, Zhou, Li, Zhang, Taiping, Zhao, Yupei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2014
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196178/
https://ncbi.nlm.nih.gov/pubmed/25149530
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak